The trading price of Bristol-Myers Squibb Co. (NYSE:BMY) floating higher at last check on Monday, April 22, closing at $49.21, 0.57% higher than its previous close.
The company’s P/E ratio in the trailing 12-month period was 12.76. In examining the 52-week price action we see that the stock hit a 52-week high of $70.93 and a 52-week low of $47.58. Over the past month, the stock has lost -4.61% in value.
Bristol-Myers Squibb Co., whose market valuation is $99.74 billion at the time of this writing. The dividend yield on the company stock is 4.76%, while its Forward Dividend ratio is 2.34. Investors’ optimism about the company’s current quarter earnings report is understandable.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Bristol-Myers Squibb Co. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest BMY has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that BMY’s price is currently -3.23% off the SMA20 and -3.73% off the SMA50. The RSI metric on the 14-day chart is currently showing 41.47, and weekly volatility stands at 1.63%. When measured over the past 30 days, the indicator reaches 1.70%. Bristol-Myers Squibb Co. (NYSE:BMY)’s beta value is currently sitting at 0.42, while the Average True Range indicator is currently displaying 0.90.
To see how Bristol-Myers Squibb Co. stock has been performing today in comparison to its peers in the industry, here are the numbers: BMY stock’s performance was 0.57% at last check in today’s session, and -29.22% in the past year. Bristol-Myers Squibb Co. has a P/E ratio of 12.76.
An evaluation of the daily trading volume of Bristol-Myers Squibb Co. (NYSE:BMY) indicates that the 3-month average is 15.57 million.
Currently, records show that 2.03 billion of the company’s shares remain outstanding. The insiders hold 0.08% of outstanding shares, whereas institutions hold 78.18%. However, since the stock’s price has seen -4.09% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
